Evaluation of the innate immune responses to influenza and liveattenuated influenza vaccine infection in primary differentiated human nasal epithelial cells 
Introduction
Influenza A viruses (IAV) remain one of the most relevant human pathogens with annual epidemics resulting in 250,000-500,000 deaths worldwide [16] . Annual vaccination against influenza viruses is required due to frequent antigenic drift and inefficient cross-protective immunity from prior infections or vaccination. Although vaccination remains the best approach against infection and disease, the identification of new circulating strains and the time for production and distribution present constraints on vaccine development. Additionally, other host-driven factors can contribute to the efficacy of influenza vaccines [9] . Defining host molecular responses-and the viral and host factors interactions that trigger and regulate them-is therefore essential to developing effective vaccines.
Live-attenuated influenza vaccine (LAIV) strains are based on the cold-adapted master donor virus A/Ann Arbor/6/1960 (H2N2). The 6:2 reassortant vaccine viruses contain the RNA segments encoding the hemagglutinin (HA) and neuraminidase (NA) surface antigens derived from circulating wild type influenza virus (WT) and the six internal RNA segments derived from the master donor virus. LAIV has been described to have three phenotypic changes that relate to its reduced ability to cause disease: (i) it causes reduced disease in animal models compared to seasonal strains of influenza (attenuation, or at) (ii) has restricted replication at temperatures at or above 39°C (temperature sensitivity or ts) and (iii) is able to efficiently replicate at temperatures as low as 25°C (cold-adaptation or ca). Although several pre-clinical [5, 6, 27, 28] and clinical studies [17, 19, 30] have demonstrated that LAIVs are safe, efficient, and an effective means of vaccination, the mediators and correlates of protection still remain poorly understood.
In this study, we use a whole-genome transcriptional approach to elucidate the early response to wild-type (WT) A/Victoria/361/2011 (H3N2) influenza A virus (A/Victoria/361/2011) and an antigenically matched LAIV strain in primary differentiated human nasal epithelial cell (hNEC) cultures. We demonstrate that LAIV elicits robust antiviral responses, which may also restrict viral replication. LAIV also induces enhanced chemokine secretion and that downstream transcriptional profiles following infection with vaccine strains are predictive of increased leukocyte and lymphocyte recruitment to sites of virus replication which may contribute to the generation of a strong adaptive immune responses. These responses are reflective of those observed in the nasal epithelium during acute infection of humans with IAV. Thus, primary differentiated hNEC cultures can model the innate immune responses present in influenza-infected individuals and provide insight into the molecular mechanisms of LAIV efficacy.
Materials and methods

Viruses
Seasonal influenza A virus A/Victoria/361/2011 (H3N2) and an antigenically-matched live attenuated influenza vaccine virus A/Victoria/361/2011 LAIV (LAIV; HA and NA RNA segments from A/Victoria/361/2011, and other RNA segments from A/Ann Arbor/6/1960) were utilized in this study. Virus seed stocks were obtained from Medimmune and virus sequences verified using MiSeq to obtain sequences for all virus segments. The viruses are referred to as H3N2 WT or LAIV in the manuscript. Working stocks were generated by infecting confluent MDCK cells at an MOI of 0.01 for 48-72 h in DMEM supplemented with 0.3% bovine serum albumin, 2 mM GlutaMax, 100 U/ml Penicillin, 100 mg/ml Streptomycin, and 4 mg/ml N-acetyl Trypsin (NAT). The supernatants were then harvested, clarified by low speed centrifugation, and aliquoted for storage at À70°C.
Cell culture conditions
Madin-Darby canine kidney (MDCK) cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum (FBS), 2 mM GlutaMax, 100 U/ml Penicillin and 100 mg/ml Streptomycin and maintained in a humidified environment at 37°C with 5% CO 2 .
Human nasal epithelial cell (hNECs) cultures (male and female donors) were obtained from non-diseased tissue during endoscopic sinus surgery for non-infection related conditions and grown in culture at the air-liquid interface (ALI) as previously described [25, 32, 33] . Female and male donors were used and the ages were between 18 and 49 years old. Tissue processing, differentiation medium, and culture conditions have been previously described in detail [12] .
Infection of primary differentiated hNECs
Differentiated hNEC cultures were infected at a multiplicity of infection (MOI) of one (high MOI) or 0.03 (low MOI) 50% tissue culture infectious dose (TCID 50 ) per cell. All incubations were performed at 32°C in a humidified environment with 5% CO 2 . Prior to infection, the apical surface of the cultures was washed with 200 ll DMEM (supplemented with 0.3% BSA, 2 mM Glutamax, 100 U/ml Penicillin, and 100 mg/ml Streptomycin) and the basolateral media was replaced with 500-1000 ll of fresh LHC Basal Medium:DMEM-H. The virus inoculum was added to the apical compartment in a volume of 100 ll and incubated for 1 h, after which the inoculum was aspirated and the apical surface was washed three times with 200 ll phosphate buffered saline containing calcium and magnesium (PBS+). The plates were then returned to the incubator. Both apical washes and basolateral medium were collected and stored at À70°C. Virus production in apical washes was quantified by determining the 50% tissue culture infectious dose (TCID 50 ) using MDCK cells [24] and the Reed-Muench algorithm [34] .
Microarray experiments and data processing
RNA was isolated from Trizol homogenates of mock, WT or LAIV infected cells harvested at 24hpi and 36hpi Fluorescent-labeled probes were generated from each sample using Agilent one-color LowInput Quick Amp Labeling Kit (Agilent Technologies). All infected samples were confirmed to express viral M2 mRNA by quantitative RT-PCR [13, 29] . Individual cRNA samples were then hybridized to oligonucleotide microarrays for gene expression profiling using SurePrint G3 Human Gene Expression v2 Microarray Kit (G4851A; Agilent Technologies.
The primary transcriptomic data was extracted and quantile normalized using the 'normalizeBetweenArrays' method available in the 'limma' package of the R statistical computing software suite and adjusted for batch effects using the ComBat software [22] . Differential expression (DE) of H3N2 WT and LAIV was determined by comparing the average ratio of virus-infected replicates to timematched and donor-matched mock-infected samples based on a linear model fit using the 'limma' package. Criteria for differential expression were an absolute fold-change of 1.5 and an adjusted pvalue of <0.05, calculated by Benjamini-Hochberg correction [3] .
Functional enrichment analysis
Functional analysis of DE genes was done using Ingenuity Pathway Analysis (IPA, Ingenuity Systems). IPA canonical pathway enrichment was calculated using a right-tailed Fisher's exact test with a threshold of significance set at p-values 0.05. Enrichment of Diseases and Biological Functions and upstream regulators analysis were based on activation |Z-scores| > 2 and p-values < 0.05. Virus-infected cells were compared to time-and donor-matched mock-infected samples.
Gene expression profile correlations
Correlation analysis of influenza signatures to cytokine response gene expression profiles derived from hNECs was performed using data available from the NCBI-GEO database under the following accession number: GSE19182. Spearman correlation coefficients (r) and confidence intervals were calculated using the 'psych' package in R statistical computing software suite. Virusinfected cells were compared to time-and donor-matched mockinfected samples.
Chemokine and cytokine measurements
Secreted chemokines and proinflammatory cytokines were quantified from the basolateral samples of both low and high MOI infections using multiplex ELISAs (MesoScale Diagnostics):
V-PLEX Human Chemokine Panel 1 (Eotaxin, Eotaxin-3, IP-10 (CXCL10), MCP-1, MCP-4, MDC, MIP-1a, MIP-1b, TARC, IL-8) and Human ProInflammatory Tissue Culture 9-Plex (GM-CSF, IFN-c, IL-1b, IL-10, IL-12p70, IL-2, IL-6, IL-8, TNF-a), respectively, following manufacturer instructions. Samples were diluted 1:2 for the proinflammatory cytokine panel and 1:4 for the chemokine panel in the provided reagent diluents and run in duplicate. Plates were washed as described above. All incubations were performed sealed at room temperature with shaking (3000 rpm). Before reading, 2x read buffer was added and the plates were incubated for 5 min (ProInflammatory 9-Plex) or read immediately (Chemokine Panel 1V-Plex) on a Meso Scale Discovery SECTOR Imager 2400. Protein concentrations were calculated using the MesoScale Diagnostics Discovery Workbench (version 4.0.12). For both assays, samples were diluted 1:4 in PBS with 1% BSA and analyzed in duplicate. The sealed plates were incubated at room temperature (with the exception of the tetramethylbenzidine, TMB, development). Plates were washed three times with 150 ul of wash buffer (PBS and 0.05% Tween-20) on an AquaMax 4000 plate washer and then blotted dry between sample, detection antibody, and streptavidin-horseradish peroxidase incubations. Results were read on a FilterMax F5 microplate reader at 450 nm (with a 540 nm reference for IFN-k) and protein concentrations were determined using SoftMax Pro 6.4.
Interferon ELISAs
RNA sequencing
Total RNA was extracted from nasal swabs collected from three individuals (2 males and 1 female) confirmed to be infected with H3N2 viruses by PCR in the 2012-13 influenza season. The individuals showed symptoms of acute respiratory infection and either fever or cough/sore throat at time of enrollment and symptom onset occurred no longer than 4 days before enrollment. Samples from the time of enrollment (day 0) or three days after enrollment (day 3) were used to assess the host responses during acute infection. Samples from day 7 post enrollment were used as baseline values because the patients were symptom free at that time. Libraries for RNA sequencing were constructed using TruSeq RNA Access kit (Illumina). The libraries were clonally amplified and sequenced on a NextSeq 500 sequencing system (Illumina). General quality control of the raw reads was performed using FastQC. Ribosomal RNA reads were removed via mapping by Bowtie (v2.1.0) [26] using an index of human, mouse, and rat rRNA sequences. The number of read pairs following ribosomal RNA removal in each sample varied from 20 million to 100 million read pairs. Each sample was randomly sampled down to 20 million reads to adjust for these differences. For each sample, about 90% of remaining reads were mapped against the human reference genome hg19, build GRCh37, from the UCSC genome browser using STAR (v2.4.0h1) [10] . Quantitative gene counts were produced utilizing the human annotation associated with the genome using the python package HT-Seq [1] . Differential gene expression analysis was done using edgeR [35] . Statistical significance cutoff was set at a fold change > |2| and an adjusted p-value of 0.05.
Statistical analysis
Statistical analyses for viral RNA expression and high MOI virus titers were performed using t-tests. Data from virus replication kinetics and protein secretion were analyzed using a Multiple Analysis of Variance (MANOVA), with time and virus as variables in GraphPad Prism version 5.0 (GraphPad software Inc. La Jolla, CA); p-values of < 0.05 were considered significant. ⁄ indicates a significant differences between WT and LAIV samples while # indicates a difference from mock-infected cultures.
Data dissemination
The hNEC microarray expression data and the nasal swab RNAseq expression data generated in this study are available via the following accession identifiers on the NCBI-GEO database: GSE83285, GSE83215 and GSE81951.
Results
Influenza A virus replication in primary differentiated human nasal epithelial cells
To better understand the response to WT and LAIV infection in differentiated hNEC cultures, cells were infected with a seasonal H3N2 isolate (A/Victoria/361/2011; WT) and the antigenicallymatched LAIV strain at a high multiplicity of infection (MOI = 1). Infectious virus production was determined at at 24 and 36 h post-infection (hpi). There was a $10-fold decrease in infectious virus production at 24 hpi (Fig. 1A, left) for LAIV compared to WT virus. At 36 hpi, there were no observable differences in infectious virus production (Fig. 1B, right) . No differences in viral mRNA transcription were detected in infected hNEC cultures at either 24 hpi (Fig. 1A , left) or 36 hpi (Fig. 1B, right) . These data confirm that LAIV infection in hNEC cultures leads to reduced infectious virus particle production but equivalent viral gene expression when compared to WT infection which has been previously demonstrated with older LAIV strains [11, 12] .
The host transcriptional response to LAIV infection is more robust than that observed with WT virus infection
Having confirmed that replication of the H3N2 LAIV strain is attenuated in hNECs, the transcriptional responses to WT and LAIV strains were evaluated to better understand host-driven factors that could contribute to viral restriction. Significant changes in gene expression (fold change > |1.5|) in virus-compared to mockinfected cells were detected at both 24 hpi ( Fig. 2A ) and 36 hpi (Fig. 2B) . Multidimensional scaling was used to visualize the expression of the 432 differentially-expressed genes (DE) across all infections. The molecular signatures that correspond to both WT and LAIV infection are robust, as they diverge from the transcriptional profiles of mock-infected samples ( Fig. 2C and D) . Importantly, gene expression across donors showed a high degree of reproducibility across replicates as well as concordance amongst distinct donors. Between the virus strains, consistent responses were identified at both 24 hpi (Fig. 2C) and 36hpi (Fig. 2D) , largely due to the observation that a majority of DE genes were shared amongst strains ( Fig. 2A and B) . However, LAIV infection elicited a greater number of significant DE genes, which was more pronounced by 36hpi (Fig. 2B) .
Host responses to viral infection are aimed at preventing viral replication and promoting pathogen clearance. To better understand the differences in the host response to infection with distinct viral strains, the subset of genes within the previously defined DE subset that showed greater than |1.2| fold-change differences between LAIV and WT viruses was examined further. Almost 60 percent of the DE genes (253 total) were found to be more impacted by LAIV infection (Fig. 2E) . Together, these data suggest that while the host response to both circulating H3N2 viruses and antigenically-matched LAIV strains is likely regulated by similar molecular pathways across distinct donors, the magnitude of these responses is enhanced in LAIV-infected cells.
LAIV infection results in enhanced type III interferon-mediated responses relative to WT virus infection
To define the host regulatory pathways involved in attenuation of LAIV strains, the transcription factors mediating the expression of the 253 genes found to be more differentially expressed in LAIV infection at both 24hpi (Fig. 3A) and 36hpi (Fig. 3B) were evaluated. Overall, the transcriptional factors predicted to regulate the LAIV signature (IRF9, RELA, RELB, STAT1, JUN) have been previously associated with the regulation of innate antiviral responses reviewed by [18] . Canonical pathway enrichment analysis revealed that the most significantly enriched (Enrichment score >1.3) pathways are involved in pathogen recognition and interferon (IFN) synthesis, response to IFN, and antigen presentation (Fig. 3B) .
IFN secretion exerts pleiotropic antiviral effects by autocrine and paracrine activation of cell membrane-associated receptors, coordinating the late phase of viral recognition and further amplifying antiviral effector functions. To identify key antiviral cytokines that coordinate the response to IAV and LAIV in hNEC cultures, the transcriptional signature captured in our study was compared with those observed following stimulation of primary differentiated respiratory epithelial cells by type I IFN, type II IFN or Th-2 polarizing cytokines [15] (Fig. 3C) . Genes responsive to both WT and LAIV viruses were highly, positively correlated to genes responsive to type I IFN (IFNa and IFNb). On the other hand, a moderate positive correlation with type II IFN responses, and no correlation with the transcriptional responses to Th2 polarizing cytokines, IL-4 and IL-13 was observed.
The type I IFN response profiles are similar to those elicited by type III IFN genes and are coordinated by overlapping signal transduction molecules [8, 41] IRF9  TEAD1  HIVEP1  MIR133B  PRDM1  FOXC1  RELA  MAPK14  RELB  SND1  JUND  MEF2A  NR5A1  STAT1  POU1F1  IRF8  TP53  NR3C1  FOXM1  NR5A2   0  5 10 15 20  Combined Score   FOXC1  TEAD1  RUNX2  IRF9  MAPK14  RELA  SND1  GATA2  NR3C1  NKX2-8  RUNX1  HIVEP1  RELB  miR133B  ETS1  ETS2  JUND  REL  BCL6  IRF8   E cell types, type III IFN receptor mediated responses are restricted to dendritic and epithelial cells which express the type III IFN receptor [2] . To elucidate the role of type I and III IFN in the transcriptional response to infection in hNECs, the relative expression of IFN genes following infection (Fig. 3D) was evaluated. Amongst all the DE genes following infection, significant increases were detected in IFNb and the IFNk genes by 24 hpi. While there was no difference in the magnitude of IFNB1 gene expression following WT or LAIV infection, induction of IFNk genes was greater in LAIVinfected compared to WT-infected cultures. The contrast in the IFNk genes was most evident by 36 hpi. Concomitant with the increased expression of these genes, was the enhanced induction of downstream IFN-stimulated genes in LAIV-infected cells (Fig. 3E) . IFNk receptor expression was not altered in response to infection. Together, these findings suggest that the attenuation of LAIV infection in hNEC cultures is correlated with enhanced induction of type III IFN-dependent innate antiviral responses.
LAIV induces greater pro-inflammatory and chemotactic responses in infected hNEC cultures
Studies into the correlates of protection of LAIV have demonstrated that unlike the inactivated vaccines, the protective nature of LAIV is independent of serum antibodies [30, 36] . Moreover, it has been demonstrated that the immunoprotection by LAIV vaccines is associated with the induction of T cell-mediated immunity [17, 19, 39] . To assess whether pro-inflammatory and chemotactic responses induced by WT virus infection differ from those induced by LAIV infection, the enrichment of genes known to affect biological functions associated with the crosstalk between innate and adaptive immune responses was examined. A unique, significant enrichment of genes involved in the chemotaxis, activation, and maturation of immune cells was observed, which dominated by 36hpi in LAIV-infected cultures (Fig. 4A) .
Transcription factors that regulate cytokine and chemokine expression (Fig. 3A) and pro-inflammatory canonical pathways (Fig. 3B, blue) were amongst the subset of genes that were more highly expressed in LAIV-infected cultures. At 36 hpi, where the induction of chemotactic responses was most robust, there was an increase in the secretion of the CXCR3 ligand CXCL10 in both WT and IAV-infected hNEC cultures with a trend toward more production in LAIV-infected cultures (Fig. 4B) . This was consistent with a significant increase in mRNA expression (Fig. 4C) , of CXCR3 targeting genes CXCL9 and CXCL10. Together, these data demonstrate that LAIV induces epithelial cell responses that may drive the increased recruitment of lymphocytes and leukocytes to the infected nasal epithelium.
Differentiated hNECs recapitulate the response H3N2 observed during acute infection
Given that hNEC cultures can capture distinct transcriptional changes following virus infection, we evaluated whether these responses were reflective of the transcriptional changes observed in the infected nasal epithelium of IAV-infected individuals. Genome-wide transcriptional profiles were determined from nasal swabs of individuals acutely infected with H3N2 IAV (Fig. 5A) . Acute gene responses (day 0 or 3 after influenza diagnosis) were compared to responses at day 7 post infection (considered baseline responses). Genes that underwent significant changes in expression (fold change >|2|, p-value < 0.05) were identified in pathways involved in T cell-specific, inflammatory, and antiviral functions, amongst other immune and metabolic functions (Fig. 5B) . The concordance of the in vivo gene expression changes with those identified in virusinfected hNEC cultures was then determined (Fig. 5C) . Overall, the expression changes captured in hNEC cultures following infection with either WT or LAIV, showed moderate correlation with the gene expression patterns observed in the nasal epithelium during acute influenza infection. These results demonstrate that primary differentiated hNEC cultures are a relevant model for evaluating the host transcriptional response to WT and LAIV infection.
LAIV replicates less efficiently, but induces a proportionally greater innate immune response than WT at late times post infection in a differentiated hNEC model of a natural infection
To determine if transcriptional responses observed in high MOI hNEC infections and from in vivo influenza infected human samples were reflected in the production of IFN, chemokines and cytokines, hNEC cultures were infected with WT and LAIV virus at a low MOI and virus replication as well as interferon and chemokine protein production was assessed at various times post infection. As in high MOI infections, LAIV infectious virus production is reduced in hNEC cultures relative to WT (Fig. 6A) , both in kinetics and peak titer. Given the reduced virus production in LAIVinfected cells, we then assessed the induction of various innate immune factors after WT or LAIV infection. IFNk production is significantly elevated following infection with both viruses, in both the apical and basolateral media relative to mock-infected cultures ( Fig. 6B and C) , mirroring the predicted type III IFN production. There was no statistically significant difference in IFNk production between WT and LAIV-infected cultures despite reduced infectious virus production in LAIV infections. Basolateral secretion of the chemokines CXCL10, CCL3, and CCL4 increases after 3days post infection in WT-and LAIV-infected hNEC cultures compared to mock infected cultures, but there is no statistical difference in production between WT and LAIV-infected cells (Fig. 7A-C) -again, despite reduced LAIV virus replication compared to WT virus. CXCL10 was detected during high MOI infections (Fig. 4B ) and showed induction in both WT and LAIV infections (Fig. 7A) . Secretion of the macrophage inflammatory proteins CCL3 and CCL4 (Fig. 7B and C) confirm the transcriptional responses involving acti- vation of leukocyte recruitment pathways (Fig. 4A) . Therefore, while the overall induction of innate immune factors is similar in LAIV and WT infected hNEC cultures at the protein level, the response is proportionally greater during LAIV infection given the reduced infectious virus production seen in LAIV-infected hNEC cultures.
Discussion
In this study, the response of differentiated human nasal epithelial cell cultures to WT and LAIV infection in vitro was examined at the transcriptional and protein level to identify the factors associated with LAIV-mediated immune protection. The hNEC cultures faithfully recapitulated the transcriptional responses present in nasal swabs of humans infected with influenza, particularly in modeling T cell-specific, inflammatory, and antiviral functions, amongst other immune and metabolic pathways. The isolation and differentiation of nasal epithelial cells provides a model to study the host epithelial cell responses at the initial site of replication, allowing both transcript analysis and confirmation of protein synthesis and secretion. This provides a targeted focus for investigating host factors involved in early immune recognition and response to WT and LAIV.
While both WT and LAIV replicate in the upper airways, only WT is able to reach the lower lungs. Despite this, many in vitro studies have used cells derived from the lower airways, such as the A549 alveolar epithelial cell carcinoma line or primary cell cultures derived from the trachea, bronchioles and alveoli [4, 20, 21, 31, 37, 38] . While these studies are useful for examining pathogenesis following lung infection, they fail to faithfully recreate the environment initially encountered by WT and LAIV. There are significant differences between the cells of the upper and lower airways, including factors such as sialic acid distribution reviewed in [23] and innate immune response [7] .
Importantly, there is also a temperature difference between the two environments: the lower airways are maintained at 37°C but the nasal epithelium is cooler, with an average temperature of 32°C
. Influenza infections are often done at 37°C and this may impact the induction of innate immune responses [14] . The experiments in this study were conducted at 32°C to mimic the temperature normally experienced by nasal epithelial cells.
As previously demonstrated for older LAIV strains [11, 12] , the replication of recent H3N2 LAIV strains was impaired relative to that of WT viruses even at a permissive temperature, suggestive of additional, epithelial-specific attenuations mediating LAIV replication efficiency. Infection with WT and LAIV resulted in a significant induction of genes primarily involved in pathogenrecognition, IFN synthesis, response to IFN stimulation, and inflammation. The stronger induction of innate immune responses in LAIV-compared to WT-infected hNECs may be one factor contributing to LAIV attenuation in hNEC cultures.
In accordance with previous studies comparing seasonal H1N1 IAV and antigenically-matched LAIV [11] , we demonstrated that LAIV can elicit enhanced innate immune responses as compared to a seasonal H3N2 IAV (WT) infection. Our study expands upon the previous finding by demonstrating that heightened innate immune responses are conserved in LAIV strains in an HA and NA antigen-independent manner. Furthermore, the current study provides a comprehensive view on the transcriptional landscape in response to infection with WT and LAIV strains. Specifically, we reveal that in hNEC cultures, the innate immune response to influenza infection is largely driven by type I and type III IFN. However, while viral recognition results in the induction of both IFNB1 and IFNL1-3 genes, LAIV infection results in a unique enhancement of the IFNL genes. While expression and secretion of type I and type III IFN following viral recognition is ubiquitous amongst cell types, the specific response to type III IFN is restricted to dendritic and epithelial cells [2] .
We demonstrate a differential induction of CXCR3 ligands, CXCL10, CXCL9, and CXCL11, which have been shown to play an important role in the recruitment of monocytes and lymphocytes to the infected tissue [40] . Importantly, CXCL10 also plays an important role in coordinating the generation of effector and memory CD8+T cells. Prior studies aimed at uncovering the correlates of protection for LAIV have demonstrated that unlike TIV vaccination, where serum HAI antibodies correlate well with protection from infection, LAIV vaccination does not elicit robust neutralizing antibody responses [30] . Rather, LAIV is thought to induce robust cellular responses and protective mucosal immune responses [17, 36, 39] . This agrees with our observation of increased secretion of the macrophage inflammatory proteins CCL3 and CCL4 following viral infection.
Our data demonstrate that viral titer may not be solely responsible for the degree of innate immune activation. The reduced infectious virus production in LAIV-infected hNEC cultures was still able to induce as strong of a response as WT infection and suggests a proportionally greater immune response to LAIV. This stronger activation of epithelial cell innate immune responses may play a role in the induction of LAIV-induced immune responses and compensate for the reduced replication of LAIV.
